Levels of resistance to tetracycline, chlortetracycline, demethylchlortetracycline, doxycycline, oxytetracycline, methacycline, pyrrolidinotetracycline, minocycline, and 0-chelocardin of Escherichia coli K-12 carrying transposon TnlO or defined DNA segments of TnlO were determined. In all cases, tetA was the only gene required for resistance. Doxycycline was the most effective inducer of tetA gene expression.
by genes of other classes (10, 13) . Although the mechanism of tetracycline resistance is not fully understood, active efflux leading to a decreased accumulation of tetracycline by resistant strains appears to be one of the essential components of the resistance mechanism (1, 9) . A common feature of the tetracycline resistance determinants of gram-negative bacteria is the regulated expression of the genes involved, i.e., the induction of the resistance genes by tetracycline (5) . The resistance genes of transposon TnWO have been studied in great detail; in the core region of this element two genes, tetA and tetR, have been located (2, 7, 14; Fig. 1 ). Gene tetR is the regulatory gene, whose product acts as a repressor for both tetA and tetR (2, 14) . Gene tetA encodes a membrane protein essential for tetracycline resistance (7) .
The purpose of this study was to compare the antibacterial activities of nine tetracyclines against Escherichia coli harboring TnlO or defined DNA fragments of TnlO. The compounds were obtained from the following sources. Tetracycline, chlortetracycline (7-chlorotetracycline), oxytetracycline (5-hydroxytetracycline) , and minocycline were purchased from Sigma Chemical Co., St. Louis, Mo. Demethylchlortetracycline (6-demethyl-7-chlortetracycline) from Cyanamid, Wolfratshausen, West Germany, and pyrrolidinotetracycline (pyrrolidinomethyltetracycline) from Hoechst, AG, Frankfurt, West Germany, were obtained from a local pharmacy. Doxycycline (a-6-deoxyoxytetracycline) and methacycline (6-methylene-tetracycline) were a gift from Mack Chemical Co., Illertissen, West Germany, and 3-chelocardin was generously supplied by Deutsche Abbott, Wiesbaden, West Germany. With the exception of P-chelocardin, all of these tetracyclines are used for therapy in humans. Growth of E. coli strain W4680 was inhibited by these tetracyclines at concentrations ranging from 0.17 to 1.6 ,uM (Table 1 ). An intact TnJO on the ColEl-derived multicopy plasmid, pCB8 (2), conferred a more than 60-fold increase in resistance upon this strain against all of the compounds tested except for P-chelocardin. Levels 1-Chelocardin, previously shown not to act as an inducer of the tetracycline resistance genes (3), was the most potent tetracycline inhibiting growth of the TnJO-carrying strain. The threefold increase in resistance observed in the TnJOcarrying strain may be accounted for by the basal level of TetA protein produced in the absence of induction. When a 2 p.M concentration of tetracycline (as inducer) was included in the test plates containing P-chelocardin, a 25 ,uM concentration of P-chelocardin was required to inhibit growth (data not shown). Thus transposon TnJO contains the genetic information for resistance against the nine tetracycline compounds tested.
Mutant derivatives of TnlO were generated to determine which section of the TnJO core region is required for the expression of resistance against various tetracyclines. Plasmid pCB129 carried a DNA fragment comprising genes tetA and tetR ( Fig. 1 ). Resistance levels mediated by pCB129 did not vary significantly from those mediated by an intact transposon (Table 1) . We conclude that no TnJO genes outside the DNA fragment present on pCB129 are required for the expression of resistance against the tetracyclines tested. A possible involvement of the tetR gene in resistance was investigated by using a TnJO mutant which lacked tetR (pCB81; Fig. 1 ) and thus expressed tetA constitutively. The levels of resistance of strain W4680 harboring pCB81 to all of the compounds tested except for P-chelocardin were consistently below the levels of resistance with pCB8 preinduced with tetracycline (Table 1) . However, the relative reduction in the resistance levels was similar, indicating the absence of any special effect of the tetR gene product in the mechanism of resistance against any of the compounds tested. (The reduced levels of resistance were not due to the absence of the tetR gene product since introduction of a functional tetR gene in W4680(pCB81) did not restore high resistance levels. Preliminary evidence indicates that the rate of TetA protein synthesis encoded by pCB81 was reduced, possibly due to a mutation in the promoter of the by compounds which inactivated the tet repressor. The level of ,B-galactosidase activity synthesized within 60 min after the addition of subinhibitory amounts of the various tetracyclines (0.1 p.M) was taken as a measure of the in vivo inducing capacity. The levels of P-galactosidase activity measured varied depending on the compound tested ( Table  2) . Comparison of the data presented in Tables 1 and 2 revealed that the differences in resistance levels between uninduced and preinduced TnlO-carrying cells (Table 1) were small when the tetracycline tested combined a high inducing capacity with antibacterial activity at low concentrations (i.e., doxycycline) and absent when the compound exhibited a high inducing capacity but a low antibacterial activity (i.e., methacycline).
Two conclusions on the antibacterial effectiveness of a tetracycline compound on bacterial strains harboring TnJO can be drawn from the data presented here. (i) When high concentrations (i.e., >200 ,uM) of the compound are needed to inhibit growth, preinduction or constitutive expression of the resistance gene (tetA) has little or no effect (Table 1) . (ii) Compounds active at low concentrations (i.e., <80 ,uM) are more effective against uninduced resistant strains when their inducing capacity is low (e.g., P-chelocardin, minocycline, and demethylchlortetracycline versus doxycycline). Tetracycline derivatives which combine a low inducing capacity with a low affinity for the TetA protein would certainly be useful against tetracycline-resistant pathogenic bacteria. We thank B. Rak and E. Schwarz for their critical reading of the manuscript.
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